Table 3 Univariate and multivariate analyses of the contribution of FOXS1 on the survival of GC patients.
From: FOXS1 is regulated by GLI1 and miR-125a-5p and promotes cell proliferation and EMT in gastric cancer
Clinical parameters | Univariate analysis | Multivariate analysis | ||
|---|---|---|---|---|
HRa (95%CI) | P value | HRa (95%CI) | P value | |
FOXS1 | 1.001 (1.000–1.003) | 0.009** | 1.002 (1.000–1.003) | 0.009** |
Age (years) | 1.022 (1.004–1.041) | 0.017** | 1.033 (1.014–1.052) | 0.001** |
T stage (T1 + T2/T3 + T4) | 1.306 (1.038–1.643) | 0.023* | 1.203 (0.931–1.555) | 0.158 |
N stage (No/Yes) | 1.259 (1.013–1.565) | 0.038* | 1.014 (0.732–1.404) | 0.934 |
M stage (No/Yes) | 1.501 (1.153–1.955) | 0.003** | 1.433 (1.095–1.876) | 0.009** |
Stage(I + II/III + IV) | 1.356 (1.119–1.642) | 0.002** | 1.254 (0.927–1.696) | 0.143 |
Grade(I + II/III + IV) | 1.194 (0.986–1.446) | 0.069 | — | — |
Tumor size(< = 10 mm/>10 mm) | 3.182 (1.614–2.671) | <0.001*** | — | — |
Gender | 1.467 (0.978–2.199) | 0.064 | — | — |
